» Articles » PMID: 36387674

Barriers to Treatment Regimen Adherence in Indian Women with Polycystic Ovarian Syndrome

Overview
Specialty Public Health
Date 2022 Nov 17
PMID 36387674
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovarian syndrome (PCOS) is a hormonal disorder that affects women of the reproductive age group. Its treatment regimen comprises medication and lifestyle modifications. However, non-adherence to the treatment regimen is the most commonly faced problem among women due to various barriers, resulting in complications like insulin resistance, hyperlipidemia, obesity, and infertility. Primary care physicians see patients with this disorder either at the initiation of treatment or on follow-up care after specialist consultation. So, understanding the barriers to treatment compliance, from a woman's perspective and finding the solution to the same is crucial to successful therapy.

Objectives: The present study aims to assess adherence to the treatment regimen and its barriers among women with PCOS and its associated factors.

Methods: A cross-sectional study among 224 women who met the inclusion criteria responded through a Google form. Self-reports were obtained by a demographic proforma, medication adherence rating scale, and barriers assessment questionnaire.

Results: Only a third of the women (32.1%) were fully adherent, 36.3% were partially adherent, and 31.6% were non-adherent. The most common barriers among women were lack of knowledge regarding the disease and its management, side effects of the treatment, long duration of the therapy, no relief of symptoms, bland diet, and lack of physical exercise. Treatment adherence was associated with socioeconomic status ( = 0.001) among women with PCOS.

Conclusion: Adherence to the treatment regimen in PCOS was poor. Successful adherence depends on how patients understand the severe implications of non-adherence to the prescribed treatment and adjust to lifestyle modifications related barriers. It is also vital for health care providers and patients to identify these barriers, address them and refine treatment strategies.

Citing Articles

Understanding metabolic patterns in polycystic ovary syndrome: Comparing lean and obese women at a family medicine clinic.

Arunachalam R, Priya K, Brindha R, Parthiban K J Family Med Prim Care. 2024; 13(5):1837-1842.

PMID: 38948599 PMC: 11213445. DOI: 10.4103/jfmpc.jfmpc_1425_23.


Knowledge, Attitude, and Practice of Lifestyle Modifications Among Saudi Women Diagnosed With Polycystic Ovary Syndrome (PCOS).

Aljuaid A, Sindi H, Alhadi W, Abu Zayied I, Althobaiti L, Imran I Cureus. 2023; 15(11):e49398.

PMID: 38146573 PMC: 10749713. DOI: 10.7759/cureus.49398.

References
1.
Ko H, Teede H, Moran L . Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC Res Notes. 2016; 9:311. PMC: 4910192. DOI: 10.1186/s13104-016-2107-2. View

2.
Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva H . Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020; 18(1):220. PMC: 7360476. DOI: 10.1186/s12916-020-01697-5. View

3.
Bazarganipour F, Taghavi S, Allan H, Hosseini N . Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study. Int J Reprod Biomed. 2018; 15(9):553-560. PMC: 5894471. View

4.
Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C . Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients. 2019; 11(10). PMC: 6836220. DOI: 10.3390/nu11102278. View

5.
Ganie M, Rashid A, Sahu D, Nisar S, Wani I, Khan J . Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study. Int J Gynaecol Obstet. 2020; 149(2):231-236. DOI: 10.1002/ijgo.13125. View